Navigation Links
Hisamitsu Pharmaceutical Announces Two New FDA Approved Over-The-Counter Pain Relief Patches
Date:5/24/2010

TORRANCE, Calif., May 24 /PRNewswire/ -- Hisamitsu, a world leader in the manufacture of external pain relieving drugs, announced the release of two products for the American market—SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100524/LA09424)

Both SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the first and only FDA approved over-the-counter pain relief patches on the market today.  

SALONPAS® PAIN RELIEF PATCH/SALONPAS® ARTHRITIS PAIN patches are formulated for the temporary relief of the mild to moderate aches and pains of the muscles and joints associated with arthritis, sprains, strains, bruises and simple backaches experienced by patients age 18 or older.  The patches are ideally suited for seniors, workers, athletes and others. New SALONPAS® patches are effective for up to 12 hours, which contrasts with competing brands that are viable only up to 8 hours.

To introduce SALONPAS® patches, Hisamitsu will distribute over 2 million free samples.  Consumers may acquire them by visiting www.jointhepainfreemovement.com. People can also join SALONPAS® Facebook page and follow SALONPAS® on Twitter.

Joining SALONPAS® Facebook page also allows individuals to engage with the community of SALONPAS users and provide resources on pain relief and pain prevention at home, the office or on the athletic field.  

SALONPAS® patches are the smarter way to relieve pain because they are safe, long lasting. Because they are patches, they go directly to the source of pain. Originally developed in Japan, SALONPAS® analgesic patches have proven safe and effective in clinical trials.  Each patch contains 10% methyl salicylate and 3% I-menthol as the active pharmaceutical ingredients. They also offer an alternative for people who have a difficulty swallowing such as children or the elderly.  

SALONPAS® patches are available at major drug stores and big box outlets such as Rite Aid, CVS Pharmacy, Walgreens, Duane Reade, and others. Suggested retail price is $7.99.

SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the latest offering from Hisamitsu Pharmaceutical, a Japan based company founded in 1847. Hisamitsu introduced the original SALONPAS® patch in 1934 and their products are sold in approximately fifty countries around the world.

For more information visit www.jointhepainfreemovement.com.


'/>"/>
SOURCE Hisamitsu America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
2. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
3. Epix Pharmaceuticals, Inc. Announces a Change in the May 28, 2010 Auction Sale of Epix Imaging Agents to June 22, 2010
4. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
5. Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference
6. Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 46th American Society of Clinical Oncology Annual Meeting
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 107th China Import and Export Fair
9. DOAR Provides Trial Consulting Services in Victory for 5,600 Women in Gender Discrimination Class Action Trial Against Pharmaceutical Giant
10. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
11. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):